Galectin Therapeutics Inc.

Historical 13F Holders

Symbol
GALT
CUSIP
363225202
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 101 10.3 M $12.6 M
2024 Q4 114 10.1 M $13.0 M
2024 Q3 92 9.78 M $26.9 M
2024 Q2 79 9.76 M $22.2 M
2024 Q1 66 7.99 M $19.1 M
2023 Q4 73 7.41 M $12.3 M
2023 Q3 63 9.07 M $17.4 M
2023 Q2 65 7.28 M $10.5 M
2023 Q1 64 7.17 M $15.0 M
2022 Q4 67 7.29 M $8.25 M
2022 Q3 63 6.94 M $11.3 M
2022 Q2 66 7.06 M $9.26 M
2022 Q1 69 7.47 M $12.0 M
2021 Q4 65 7.50 M $15.5 M
2021 Q3 78 7.29 M $28.2 M
2021 Q2 82 7.92 M $25.3 M
2021 Q1 82 9.94 M $22.7 M
2020 Q4 89 10.9 M $24.3 M
2020 Q3 78 10.1 M $26.9 M
2020 Q2 81 10.2 M $31.1 M
2020 Q1 84 9.68 M $19.0 M
2019 Q4 86 10.6 M $30.3 M
2019 Q3 88 9.39 M $34.4 M
2019 Q2 90 9.26 M $38.4 M
2019 Q1 72 7.30 M $37.3 M
2018 Q4 70 6.02 M $20.8 M
2018 Q3 71 6.03 M $36.2 M
2018 Q2 79 5.60 M $35.6 M
2018 Q1 70 4.99 M $23.6 M
2017 Q4 54 3.74 M $12.5 M
2017 Q3 55 3.89 M $8.30 M
2017 Q2 57 3.98 M $9.79 M
2017 Q1 51 3.72 M $8.55 M
2016 Q4 47 2.86 M $2.80 M
2016 Q3 53 3.04 M $3.43 M
2016 Q2 56 3.50 M $8.82 M
2016 Q1 56 3.50 M $5.01 M
2015 Q4 63 3.60 M $9.98 M
2015 Q3 53 2.66 M $7.02 M
2015 Q2 61 3.33 M $9.08 M
2015 Q1 66 4.07 M $13.6 M
2014 Q4 65 3.76 M $13.0 M
2014 Q3 70 4.41 M $22.2 M
2014 Q2 72 4.32 M $59.7 M
2014 Q1 60 3.54 M $53.9 M